Professor of Medicine, University Louisville School of Medicine
Nephrology
Dr. George Aronoff, MD
|
|
Give Review
George Aronoff works in the field of Nephrology. He attended Indiana University School of Medicine. Indiana University School of Medicine is ranked 45 in research and 47 in primary care medicine He received awards:"Regional Top Doctor", "Whos Who in Medicine and Healthcare" and "Top MD". George Aronoff is a published physician as well. He has 88 publications published. The latest was: Informatics and end-stage renal disease. George Aronoff accepts Medicare.
Publications
- Iron dosing in Kidney disease: inconsistency of evidence and clinical practice.
- Cocaine-induced Acute interstitial nephritis: A case report and review of the literature.
- Antimicrobial therapy in patients With impaired renal function.
- The effect of oxygen on sodium excretion in hypoxemic patients with Chronic obstructive lung disease.
- Atriopeptin III kinetics and pharmacodynamics in normal and anephric rats.
- Fluoxetine: clinical pharmacology and physiologic disposition.
- Short-term augmented Calcium intake has no effect on sodium homeostasis.
- Bronchopulmonary Disease: an association with ulcerative colitis and pyoderma gangrenosum.
- Mezlocillin dose dependent elimination kinetics in Renal impairment.
- Evaluation of a microcomputer program for predicting tobramycin serum concentrations.
- Relationship between body store of vitamin B6 and plasma pyridoxal-P clearance: metabolic balance studies in humans.
- Mezlocillin pharmacokinetics in Renal impairment.
- Unusual presentation of a secondary malignancy With an unknown and a known primary malignancy.
- Nonsteroidal anti-inflammatory drug induced Renal syndromes.
- Benoxaprofen kinetics in Renal impairment.
- Pharmacokinetics of common antibiotics used in continuous ambulatory peritoneal dialysis.
- Management of amikacin overdose.
- Effects of vancomycin on Renal function in rats.
- Cryptococcal arthritis after Renal transplantation.
- Ceftazidime nephrotoxicity in rats.
- Effects of moxalactam and cefotaxime on rabbit Renal tissue.
- Nitrendipine kinetics in normal and impaired Renal function.
- Tyrosine phosphorylation of human platelet plasma membrane Ca(2+)-ATPase in Hypertension.
- Therapeutic implications associated With renal studies of nabumetone.
- Kinetics and pharmacodynamics of atrial natriuretic peptide and lithium clearance in the isolated perfused rat Kidney.
- Effect of positive and negative pressure breathing on sodium and water excretion.
- Sodium kinetics in salt-sensitive and salt-resistant normotensive and Hypertensive subjects.
- Effect of Acute renal failure on insulin disposition in the isolated perfused rat kidney.
- Mezlocillin kinetics in hepatic insufficiency.
- Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis.
- Vancomycin kinetics during continuous ambulatory peritoneal dialysis.
- Informatics and end-stage renal Disease.
- Goal setting & Network 9/10 efforts to improve care.
- Drugs and the Kidney.
- Mezlocillin elimination in patients With impaired renal function.
- NephTrak and the Renal Network Data System (TRNDS).
- Effect of protein intake on Renal function and structure in partially nephrectomized rats.
- Case report: Acute focal bacterial pyelonephritis (lobar nephronia)--presentation as a palpable abdominal mass.
- Moxalactam pharmacokinetics during hemodialysis.
- Pharmacokinetics and protein binding of cefamandole and its 1-methyl-1 H-tetrazole-5-thiol side chain in subjects With normal and impaired renal function.
- Atrial natriuretic factor in spinal cord injury.
- Pharmacokinetics of moxalactam in patients With normal and impaired renal function.
- Hepatitis B virus vaccine: a randomized trial of a reduced dose regimen in hemodialysis patients.
- Interactions of moxalactam and tobramycin in normal volunteers and in patients With impaired renal function.
- Use of drugs in patients With renal insufficiency. Workshop report.
- Pharmacokinetics of nitrendipine in patients with renal Failure: comparison to normal subjects.
- Hemodynamic, Renal, and hormonal responses to lower body positive pressure in human subjects.
- Tobramycin kinetics during continuous ambulatory peritoneal dialysis.
- Pharmacodynamics of atrial natriuretic peptide in isolated perfused Dahl rat Kidneys.
- Relationship between rat Renal accumulation of gentamicin, tobramycin, and netilmicin and their nephrotoxicities.
- Mezlocillin enteral absorption in rabbits.
- Aminoglycoside accumulation kinetics in rat Renal parenchyma.
- Initial intraperitoneal therapy for CAPD peritonitis: the Network 9 Peritonitis Study.
- Platelet Calcium transport in hypertension.
- Hypoxanthine-arabinoside pharmacokinetics after adenine arabinoside administration to a patient with renal Failure.
- Intra- and interindividual variability in sodium intake in normal subjects and in patients With renal insufficiency.
- The effect of piperacillin dose on elimination kinetics in Renal impairment.
- Nizatidine disposition in subjects With normal and impaired renal function.
- Interactions of ceftazidime and tobramycin in patients With normal and impaired renal function.
- Application of artificial neural networks to clinical pharmacology.
- Neural network predicted peak and trough gentamicin concentrations.
- Drug prescribing in renal Failure: dosing guidelines for adults.
- Bioavailability and kinetics of cibenzoline in patients With normal and impaired renal function.
- Population pharmacokinetics of the active metabolite of nabumetone in Renal dysfunction.
- Erythropoietin-induced antinatriuresis mediated by angiotensin II in perfused Kidneys.
- Low-dose recombinant human erythropoietin therapy in Chronic hemodialysis patients.
- The treatment of anemia With low-dose recombinant human erythropoietin.
- Just the FAQs: frequently asked questions about iron and anemia in patients with chronic Kidney disease.
- Pharmacokinetics of oral glyburide in subjects with non-insulin-dependent diabetes mellitus and renal Failure.
- Drug dosing consideration in patients with Acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).
- Determining optimum hemoglobin sampling for anemia management from every-treatment data.
- Massive cystic liver in a patient with autosomal dominant polycystic Kidney disease.
- Pharmacokinetics of dexrazoxane in subjects with impaired Kidney function.
- Randomized trial of model predictive control for improved anemia management.
- Iron, inflammation, dialysis adequacy, nutritional status, and hyperparathyroidism modify erythropoietic Response.
- Recognizing and reacting to product-related adverse events in hemodialysis.
- Hemoglobin variability in anemia of chronic Kidney disease.
- Model predictive control of erythropoietin administration in the anemia of ESRD.
- Model predictive control With reinforcement learning for drug delivery in renal anemia management.
- Using clinical information in goal-oriented learning.
- Individualization of pharmacological anemia management using reinforcement learning.
- Dose adjustment in renal impairment: response from Drug Prescribing in Renal Failure.
- Safety of intravenous iron in clinical practice: implications for anemia management protocols.
- Making sense: a scientific approach to intravenous iron therapy.
- Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens.
- Pharmacokinetics of linezolid in subjects With renal dysfunction.
- Comparison of urea reduction ratio and hematocrit data reported in different data systems: results from the Centers for Medicare & Medicaid Services and the Renal Netw...
Schools
Indiana University School Of Medicine
Indiana University Medical Center
Indiana University
Procedures Preformed
- Arteriovenostomy for Renal Dialysis
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Glomerulonephritis
- Acute Kidney Failure
- Amyloidosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- MHS HIX
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Preferred PPO
- Sagamore Plus
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Regional Top Doctor
- Whos Who in Medicine and Healthcare
- Top MD
Education
-
Indiana University School of Medicine
Hospital
-
Jewish Hospital -
Norton Hospital -
University of Louisville Hospital
Drug Facts
| NPI NUMBER | 1861470528 | |
| NPPES Provider LastName | ARONOFF | |
| NPPES Provider FirstName | GEORGE | |
| NPPES Provider ZIPCode | 402021715 | |
| NPPES Provider State | KY | |
| Specialty Description | Nephrology | |
| Total Claim Count | 1070.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861470528 |
| Last Name Of The Provider | ARONOFF |
| First Name Of The Provider | GEORGE |
| View All |
Similar Doctors
|
Dr. Chaisak Pengvanich, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Rosemary Ouseph, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bhagwan Bhimani, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael M. Schissler, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Danny Woo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mansoor I. Tiwana, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jon Klein, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Hania Kassem, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Stephen J. Keiran Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leslie F. Yazel, MD |
|
|
Dr. Harmeet S. Gurm, MD |
|
|
Eugene Klingler |